These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Influence of tumor size on oncological outcomes of pathological T3aN0M0 renal cell carcinoma treated by radical nephrectomy. Chen L, Ma X, Li H, Gu L, Li X, Gao Y, Xie Y, Zhang X. PLoS One; 2017; 12(3):e0173953. PubMed ID: 28288191 [Abstract] [Full Text] [Related]
29. Scoring algorithm to predict survival after nephrectomy and immunotherapy in patients with metastatic renal cell carcinoma: a stratification tool for prospective clinical trials. Leibovich BC, Han KR, Bui MH, Pantuck AJ, Dorey FJ, Figlin RA, Belldegrun A. Cancer; 2003 Dec 15; 98(12):2566-75. PubMed ID: 14669275 [Abstract] [Full Text] [Related]
30. Prognostic role of tumour multifocality in renal cell carcinoma. Siracusano S, Novara G, Antonelli A, Artibani W, Bertini R, Carini M, Carmignani G, Ciciliato S, Cunico SC, Lampropoulou N, Longo N, Martorana G, Minervini A, Mirone V, Simeone C, Simonato A, Valotto C, Zattoni F, Ficarra V, members of the SATURN Project - LUNA Foundation. BJU Int; 2012 Dec 15; 110(11 Pt B):E443-8. PubMed ID: 22502873 [Abstract] [Full Text] [Related]
33. Oncological efficacy and safety of nephron-sparing surgery for selected patients with locally advanced renal cell carcinoma. Margulis V, Tamboli P, Jacobsohn KM, Swanson DA, Wood CG. BJU Int; 2007 Dec 15; 100(6):1235-9. PubMed ID: 17979923 [Abstract] [Full Text] [Related]
34. Prognostic factors influencing long-term survival of patients undergoing nephron-sparing surgery for nonmetastatic renal-cell carcinoma (RCC) with imperative indications. Haferkamp A, Kurosch M, Pritsch M, Hatiboglu G, Macher-Goeppinger S, Pfitzenmaier J, Pahernik S, Wagener N, Hohenfellner M. Ann Surg Oncol; 2010 Feb 15; 17(2):544-51. PubMed ID: 19953334 [Abstract] [Full Text] [Related]
35. Extent of lymph node dissection at nephrectomy affects cancer-specific survival and metastatic progression in specific sub-categories of patients with renal cell carcinoma (RCC). Capitanio U, Suardi N, Matloob R, Roscigno M, Abdollah F, Di Trapani E, Moschini M, Gallina A, Salonia A, Briganti A, Montorsi F, Bertini R. BJU Int; 2014 Aug 15; 114(2):210-5. PubMed ID: 24854206 [Abstract] [Full Text] [Related]
36. A Novel Predictor of Survival with Renal Cell Carcinoma After Nephrectomy. Peng D, He ZS, Li XS, Tang Q, Zhang L, Yang KW, Yu XT, Zhang CJ, Zhou LQ. J Endourol; 2017 Apr 15; 31(4):397-404. PubMed ID: 28121179 [Abstract] [Full Text] [Related]
40. The effect of renal function change on renal cell carcinoma patients with tumor thrombus after nephrectomy and thrombectomy: a large Chinese center experience. Liu Z, Tang S, Tian X, Zhang H, Wang G, Zhang S, Ma L. BMC Cancer; 2020 Jan 28; 20(1):61. PubMed ID: 31992244 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]